Cadrenal Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Cadrenal Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cadrenal Therapeutics Inc
Rating: 1.31525
Author: Trendlyne DVM scores

about

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and dea...

12.96 -0.33 (-2.48%)

43.41% Fall from 52W High

15,105

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.0 / 100

Technically Neutral

47.6 / 100

No estimates available

Cadrenal Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cadrenal Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and dea...

43.41% Fall from 52W High

SWOT Analysis

Cadrenal Therapeutics Inc Live Price Chart